Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia
ConditionArrhythmia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorWonju Severance Christian Hospital
About this trial
The HELP-A study is a multicenter, randomized, controlled trial. A total of 588 patients were enrolled during the 4-year enrollment period and followed for 1 month. This study aims to compare the diagnostic yield of a continuous ECG patch versus an intermittent handheld ECG in patients with arrhythmia symptoms.
Eligibility criteria
Qualifiers
Patients who have arrhythmia symptoms but are not diagnosed on a 12-lead electrocardiogram and require additional tests.
Patients who can use a smartphone
Disqualifiers
Patients who have cardiac implantable electronic devices(CIEDs)
Patients who can't use handheld ECG
Patient who had syncope
Trial design
Treatments tested in this trial
- Continous ECG Patch
- Intermittent handheld ECG
Treatment groups
588 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov